CTX-M-14, a plasmid-mediated CTX-M type extended-spectrum beta-lactamase isolated from Escherichia coli

Antimicrob Agents Chemother. 2002 Jun;46(6):1985-8. doi: 10.1128/AAC.46.6.1985-1988.2002.

Abstract

Four Escherichia coli isolates harboring CTX-M-14, with a single Ala231-->Val substitution compared to CTX-M-9, had three different ribotypes. Cefotaxime resistance was plasmid encoded and conjugatively transferable. Three isolates had the same plasmid restriction enzyme digestion profile, suggesting clonal spread of a resistant plasmid. A high k(cat)/K(m) value for cefotaxime (20.3 microM(-1) s(-1)) but low values for ceftazidime and aztreonam (< 0.02 microM(-1) s(-1)) were observed in hydrolysis assays, indicating resistance to cefotaxime (MIC > or = 64 microg/ml) but susceptibility to ceftazidime (MIC < or = 2 microg/ml).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Substitution
  • Aztreonam / pharmacology
  • Cefotaxime / pharmacology
  • Ceftazidime / pharmacology
  • Cephalosporin Resistance
  • Cephalosporins / pharmacology
  • Escherichia coli / drug effects
  • Escherichia coli / enzymology*
  • Escherichia coli / genetics*
  • Isoelectric Focusing
  • Kinetics
  • Microbial Sensitivity Tests
  • Monobactams / pharmacology
  • Plasmids / genetics*
  • RNA, Bacterial / genetics
  • Reverse Transcriptase Polymerase Chain Reaction
  • Taiwan / epidemiology
  • beta-Lactamases / genetics*
  • beta-Lactamases / metabolism*

Substances

  • Cephalosporins
  • Monobactams
  • RNA, Bacterial
  • Ceftazidime
  • beta-lactamase CTX-M-14
  • beta-Lactamases
  • Aztreonam
  • Cefotaxime